1. Gene expression, levels and polymorphism (Ala16Val) of mitochondrial superoxide dismutase in tuberculosis patients of Rajasthan.
- Author
-
Gauba K, Gupta S, Shekhawat J, Dutt N, Yadav D, Nag VL, Rao M, Sharma P, and Banerjee M
- Subjects
- Humans, India, Genotype, Superoxide Dismutase genetics, Superoxide Dismutase metabolism, Gene Expression, RNA, Messenger, Polymorphism, Single Nucleotide, Polymorphism, Genetic, Tuberculosis genetics
- Abstract
Background: Infectious diseases cause redox imbalance and oxidative stress (OS) in host. Superoxide Dismutases(SOD) decrease this OS. SOD2 gene polymorphism can influence the expression and levels of enzyme., Aim: To investigate the association of genetic polymorphism of MnSOD with enzyme levels and mRNA expression in TB patients., Methods: A total of 87 TB patients and 85 healthy individuals participated in the study. The serum SOD2 levels were measured by ELISA. Gene polymorphism was analysed using PCR-RFLP with BsaW1 as the restriction enzyme. Expression was studied by Real-TimePCR. Statistical significance was determined using the Mann-Whitney, Chi-square and Kruskal-Wallis tests and p value < 0.05 was considered statistically significant., Results: The median(IQR) serum SOD2 levels of TB patients were lower than those of healthy subjects (4.64(6.48) vs 11.35(20.36)ng/mL respectively,p < 0.001). SOD2 expression was significantly down-regulated in TB patients with a fold change value of 0.312. The Val/Val genotype was higher in the patient group than healthy subjects (36.8% vs 23.5%). However, the difference observed between serum SOD2 levels and mRNA expression in the different genotypes were statistically non-significant., Conclusion: Significant difference was found between levels and expression of SOD2 in TB patients and healthy controls, but not for SOD2 gene polymorphism., Competing Interests: Declaration of competing interest The authors have declared that no competing interests exist., (Copyright © 2022 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF